A fourteen gene GBM prognostic signature identifies association of immune response pathway and mesenchymal subtype with high risk group.
BACKGROUND: Recent research on glioblastoma (GBM) has focused on deducing gene signatures predicting prognosis. The present study evaluated the mRNA expression of selected genes and correlated with outcome to arrive at a prognostic gene signature. METHODS: Patients with GBM (n = 123) were prospectiv...
| Published in: | PLoS ONE |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Online Access: | http://europepmc.org/articles/PMC3639942?pdf=render |
